Capital Markets, M&A Specialist, Hospitality & Gaming Finance

A seasoned financier with deep expertise in private equity, mergers and acquisitions, private banking, and real estate development. His diverse portfolio spans IT finance, hospitality, and gaming, demonstrating his versatility and strategic acumen across various sectors.

In 2008, Aiden made a significant mark by financing and becoming the largest shareholder of Shin Myung BNF, one of South Korea’s top three food suppliers, listed on the Kosdaq. His strategic foresight continued to shine in 2017 when he financed INCON, a Kosdaq-listed company that successfully entered the Nasdaq through a reverse merger with Variant.

Aiden’s influence grew in 2019 as he financed Central Bio, becoming its second-largest shareholder, further solidifying his reputation as a key player in the industry. Most recently, in 2023, he financed B2N, a Kosdaq-listed company, securing his position as a major shareholder. Aiden Yoon’s career is marked by his ability to identify and capitalize on high-potential investments, making him a leading figure in global finance.